Drug intelligence / Profile preview

LibidUp-PE

Development stage
Unknown
Lead developer
MMC Pharmaceuticals
Modality
Small Molecules
Administration
Oral
01

Overview

LibidUp-PE is a nutraceutical supplement developed by MMC Pharmaceuticals (marketed under their Ziva division) specifically for the management of premature ejaculation (PE) and male sexual dysfunction. Formulated as a 10g sachet, it contains a combination of essential amino acids, vitamins, and herbal extracts, including L-arginine, L-tryptophan, myo-inositol, D-chiro-inositol, vitamin B6, grape seed extract, and Safed Musli. The product is designed to enhance sexual wellness, boost stamina and vigor, and regulate the ejaculatory cycle. Clinical data from a 2023 randomized, double-blind crossover study demonstrated that LibidUp-PE significantly improves intravaginal ejaculatory latency time (IELT) and reduces post-ejaculatory refractory time (PERT). Its mechanism of action involves increasing plasma serotonin levels, which helps delay ejaculation, and enhancing blood flow to address concerns like erectile dysfunction. It is currently marketed in India.

Brand names
LibidUp-PE

Beyond the preview

Go deeper on LibidUp-PE.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on LibidUp-PE.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call